C.

Welcome to the Brand page for “C.”, which is offered here for The mark consists of stylized c with a circle between the opening.;human pharmaceuticals for the treatment of cardiovascular diseases, pulmonary diseases, pulmonary conditions, bronchoconstrictive diseases, bronchoconstrictive conditions, diseases and conditions associated with cardiac muscle dysfunction, cardiac muscle wasting, cardiac muscle atrophy, cardiac muscle weakness, infectious diseases,neurological diseases and conditions, neuromuscular diseases and conditions, musculoskeletal disorders, and diseases and conditions associated with skeletal muscle dysfunction, skeletal muscle wasting, skeletal muscle atrophy, skeletal muscle weakness, metabolic diseases and disorders, diabetes, hypertension, vascular diseases, and diseases and conditions associated with dysfunction of non-muscle myosin;color is not claimed as a feature of the mark.;research in the field of cellular assay screening and pharmaceutical discovery and development;.

Its status is currently believed to be active. Its class is unavailable. “C.” is believed to be currently owned by “Cytokinetics, Incorporated”.

Owner:
CYTOKINETICS, INCORPORATED
Owner Details
Description:
The mark consists of stylized C with a circle between the opening.;human pharmaceuticals for the treatment of cardiovascular diseases, pulmonary diseases, pulmonary conditions, bronchoconstrictive diseases, bronchoconstrictive conditions, diseases and conditions associated with cardiac muscle dysfunction, cardiac muscle wasting, cardiac muscle atrophy, cardiac muscle weakness, infectious diseases,neurological diseases and conditions, neuromuscular diseases and conditions, musculoskeletal disorders, and diseases and conditions associated with skeletal muscle dysfunction, skeletal muscle wasting, skeletal muscle atrophy, skeletal muscle weakness, metabolic diseases and disorders, diabetes, hypertension, vascular diseases, and diseases and conditions associated with dysfunction of non-muscle myosin;Color is not claimed as a feature of the mark.;research in the field of cellular assay screening and pharmaceutical discovery and development;
Categories: